1. Home
  2. MDV vs ELTX Comparison

MDV vs ELTX Comparison

Compare MDV & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Modiv Industrial Inc. Class C

MDV

Modiv Industrial Inc. Class C

HOLD

Current Price

$14.53

Market Cap

147.9M

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$8.04

Market Cap

134.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDV
ELTX
Founded
2015
2011
Country
United States
United States
Employees
N/A
26
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
147.9M
134.1M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
MDV
ELTX
Price
$14.53
$8.04
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$13.00
AVG Volume (30 Days)
35.5K
93.4K
Earning Date
03-03-2026
11-13-2025
Dividend Yield
8.07%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$47,479,000.00
N/A
Revenue This Year
$0.13
N/A
Revenue Next Year
$0.71
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.62
$4.60
52 Week High
$17.15
$12.62

Technical Indicators

Market Signals
Indicator
MDV
ELTX
Relative Strength Index (RSI) 52.90 49.78
Support Level $14.21 $7.48
Resistance Level $14.50 $8.59
Average True Range (ATR) 0.28 0.40
MACD 0.01 0.03
Stochastic Oscillator 70.86 57.70

Price Performance

Historical Comparison
MDV
ELTX

About MDV Modiv Industrial Inc. Class C

Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

Share on Social Networks: